Key Takeaways
- • Centrus Energy (LEU) achieved a Relative Strength (RS) Rating of 84 as of April 20, 2026, representing a significant upgrade from 80 and crossing into the institutional investor preference threshold of 80-plus performance percentile.
- • The RS Rating improvement reflects improving 52-week price momentum, a key technical indicator tracked by institutional investors for stock selection and portfolio weighting decisions.
- • Centrus Energy has emerged as a "pure play" on U.S. nuclear fuel reshoring, with the stock surging approximately 264% in 2025 as capital deployed toward domestic nuclear fuel supply strategy.
- • The company holds a $900 million fixed-price task order award with up to $170 million in options tied to HALEU (High-Assay Low-Enriched Uranium) production, supporting long-term revenue visibility.
- • Analyst consensus as of April 21, 2026 rates LEU as a "Buy" across 11 covered analysts, though valuation concerns persist with commentary noting the company "barely generates profits" with "falling margins," according to StockStory research.
Summary
Centrus Energy (LEU) cleared a critical technical milestone on April 20, 2026, with its Relative Strength (RS) Rating advancing from 80 to 84, according to Investor's Business Daily. The RS Rating, which measures a stock's 52-week price performance on a scale of 1 to 99, has become an important institutional screening metric. This upgrade reflects sustained momentum and places the stock into a higher percentile of relative strength, a threshold many portfolio managers use to identify stocks with superior near-term price trends.
The rating advancement follows a series of incremental upgrades. Earlier in the week, LEU had moved from 70 to 73, and supplemental sources indicate a prior upgrade from 67 to 74, suggesting a consistent positive trajectory in technical momentum. For institutional investors evaluating capital allocation into the nuclear energy supply chain, these successive upgrades indicate growing institutional participation and improving price action.
Centrus Energy has captured significant investor attention as a "pure play" on U.S. nuclear fuel reshoring—a strategic priority for domestic energy security and decarbonization. The company surged approximately 264% in 2025 as capital repositioned toward domestic nuclear supply alternatives. This narrative has been bolstered by a $900 million fixed-price task order award with up to $170 million in options tied to HALEU (High-Assay Low-Enriched Uranium) production, providing concrete revenue visibility and reducing policy execution risk.
However, analyst consensus presents a nuanced picture. While 11 covered analysts maintain a "Buy" consensus rating as of April 21, 2026, profit quality concerns merit scrutiny. StockStory research notes the company "barely generates profits" and has experienced "falling margins," suggesting that the 264% rally may have run ahead of fundamental earnings accretion. Investors should calibrate technical strength signals against underlying profitability trends and margin trajectory before deploying capital at current valuations.
The rating advancement follows a series of incremental upgrades. Earlier in the week, LEU had moved from 70 to 73, and supplemental sources indicate a prior upgrade from 67 to 74, suggesting a consistent positive trajectory in technical momentum. For institutional investors evaluating capital allocation into the nuclear energy supply chain, these successive upgrades indicate growing institutional participation and improving price action.
Centrus Energy has captured significant investor attention as a "pure play" on U.S. nuclear fuel reshoring—a strategic priority for domestic energy security and decarbonization. The company surged approximately 264% in 2025 as capital repositioned toward domestic nuclear supply alternatives. This narrative has been bolstered by a $900 million fixed-price task order award with up to $170 million in options tied to HALEU (High-Assay Low-Enriched Uranium) production, providing concrete revenue visibility and reducing policy execution risk.
However, analyst consensus presents a nuanced picture. While 11 covered analysts maintain a "Buy" consensus rating as of April 21, 2026, profit quality concerns merit scrutiny. StockStory research notes the company "barely generates profits" and has experienced "falling margins," suggesting that the 264% rally may have run ahead of fundamental earnings accretion. Investors should calibrate technical strength signals against underlying profitability trends and margin trajectory before deploying capital at current valuations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.